<DOC>
	<DOCNO>NCT00710580</DOCNO>
	<brief_summary>Compare efficacy ABT-874 versus etanercept subject moderate severe plaque psoriasis</brief_summary>
	<brief_title>Study Comparing Efficacy Safety ABT-874 Etanercept Placebo Subjects With Moderate Severe Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis Psoriasis 6 MO BSA 10 % PASI 12 PGA 3 Previous exposure either etanercept ABT874</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>